FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Bedward Royce

2. Date of Event Requiring Statement (MM/DD/YYYY)
2/26/2014 

3. Issuer Name and Ticker or Trading Symbol

HOSPIRA INC [HSP]

(Last)        (First)        (Middle)

C/O HOSPIRA, INC., 275 NORTH FIELD DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
SVP, General Counsel and Sec'y /

(Street)

LAKE FOREST, IL 60045       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   7629   D    
Common Stock   8636   (1) D    
Common Stock   7806   (2) D    
Common Stock   637.05   I   See Note   (10)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to buy)     (3) 3/6/2015   Common Stock   7000   $43.18   D    
Stock Options (Right to buy)     (4) 2/11/2017   Common Stock   8200   $49.64   D    
Stock Options (Right to buy)     (5) 2/24/2018   CommonStock   5351   $52.61   D    
Stock Options (Right to buy)     (6) 3/1/2019   Common Stock   9980   $35.36   D    
Stock Options (Right to buy)     (7) 2/27/2020   Common Stock   30488   $28.95   D    
Stock Options (Right to buy)     (8) 2/26/2021   Common Stock   29630   $42.70   D    
Perf-based Restricted Stock Units     (9) 2/27/2016   Common Stock   4826   $0   (9) D    

Explanation of Responses:
( 1)  Award of time-vested restricted stock units on February 27, 2013. The units vest over a three-year period beginning on the first anniversary of the date of grant in equal installments of one-third per year, based on continued employment. Thus, the RSUs will vest on February 27, 2014, 2015, and 2016, and are paid out only in Hospira stock, unless forfeited earlier for voluntary departure or termination for cause.
( 2)  Award of time-vested restricted stock units on February 26, 2014. The units vest over a three-year period beginning on the first anniversary of the date of grant in equal installments of one-third per year, based on continued employment. Thus, the RSUs will vest on February 26, 2015, 2016, and 2017, and are paid out only in Hospira stock, unless forfeited earlier for voluntary departure or termination for cause.
( 3)  The stock options, granted on March 6, 2008, vest in three equal annual installments on March 6, 2009, 2010, and 2011. The exercise price of $43.18 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term.
( 4)  The stock options, granted on February 11, 2010, vest in three equal annual installments on February 11, 2011, 2012, and 2013. The exercise price of $49.64 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term.
( 5)  The stock options, granted on February 24, 2011, vest in four equal annual installments on February 24, 2012, 2013, 2014 and 2015. The exercise price of $52.61 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term.
( 6)  The stock options, granted on March 1, 2012, vest in four equal annual installments on March 1, 2013, 2014, 2015 and 2016. The exercise price of $35.36 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term.
( 7)  The stock options, granted on February 27, 2013, vest in four equal annual installments on February 27, 2014, 2015, 2016 and 2017. The exercise price of $28.95 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term.
( 8)  The stock options, granted on February 26, 2014, vest in four equal annual installments on February 26, 2015, 2016, 2017 and 2018. The exercise price of $42.70 is the average of the high and low trading prices of Hospira common stock on the date of grant. The stock options have a seven-year term.
( 9)  This award constitutes a performance-contingent restricted stock unit award under Hospira's 2004 Long-Term Stock Incentive Plan. The award will vest if Hospira's stock price appreciates to a level of 120% over the fair market value on the date of grant, and maintains that appreciation for a 30 consecutive trading day period (based on Hospira's closing market price on those 30 consecutive days). This appreciation may be accomplished at any time over the next three-year period. If this performance trigger is met, then they will vest and will be paid out in Hospira shares at the end of the three-year period, unless forfeited for voluntary departure or termination for cause prior to that time. If the performance trigger is not met during the three-year period, and the award does not vest, the award will expire and no Hospira shares will be paid out. The fair market value on February 27, the grant date, is the average of the high and low stock price on that date, or $28.95
( 10)  Balance in the Hospira Stock Retirement Plan as of March 3, 2014.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Bedward Royce
C/O HOSPIRA, INC.
275 NORTH FIELD DRIVE
LAKE FOREST, IL 60045

SVP, General Counsel and Sec'y

Signatures
Benjamin Kwakye, Attorney in Fact 3/7/2014
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jun 2024 até Jul 2024 Click aqui para mais gráficos Hospira.
Hospira (NYSE:HSP)
Gráfico Histórico do Ativo
De Jul 2023 até Jul 2024 Click aqui para mais gráficos Hospira.